US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2483 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
PR953, Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
FDA901, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BRC961, Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores

Newly added tissue microarrays in recent month:

2016-09-23 T113b, Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replacing T113a
2016-09-22 T203c, Lymphoma tissue array with normal lymph node tissue, 12 cases/ 24 cores, replacing T203b
2016-09-21 HBre-Duc140Sur-02, Breast carcinoma, 140 cases. 1 core/case with survival data
2016-09-19 HBreD075Bc01, Breast invasive ductal carcinoma tissue microarray (75 cases), replacing HBre-Duc068Bch-01. ER, PR, Her2 available
2016-09-19 HBlaU066Su01, Bladder carcinoma tissue microarray (56 cases) and normal adjacent tissue. With survival data. Replaces HBla-Uro105Sur-01
2016-09-18 BS20011b, Lymphoma tissue array, 30 cases/ 30 cores, replacing BS20011a
2016-09-18 MC2082b, Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replacing MC2082a
2016-09-18 PA1921a, Advanced stage pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores, replacing PA1921
2016-09-18 T201a, Lymphoma tissue array, with normal lymph node tissue, 6 cases/24 cores, replacing T201
2016-09-18 BR20837a, Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, 104 cases/ 208 cores, replacing BR20837
2016-09-13 LC241f, Lung cancer tissue array with matched adjacent normal lung tissue, including TNM, clinical stage and pathology grade, 6 cases/ 24 cores, replacing LC241e
2016-09-12 T173b, Cerebrum cancer tissue array, with normal tissue, including pathology grade, 2 serial sections, 6 cases/ 24 cores, replacing T173a
2016-09-12 LC1005a, Lung cancer progression tissue array, including TNM, clinical stage and pathology grade, 100 cases/100 cores, replacing LC1005
2016-09-05 HBre-Duc150Sur-02, Breast carcinoma tisuse array, 150 cases. 1 core/case. Clinical Stage I, II, III. With survival data. Replaced by HBreD145Su02 (141 same cases)
2016-09-05 HBreD145Su02, Breast carcinoma tissue array, 145 cases, 1 core/case. Clinical stage 0, I, II, III. With survival data. Replacing HBre-Duc150Sur-02 (141 same cases)
2016-09-05 MC642, Neuroblastoma and peripheral nerve tissue array, 32 cases/ 64 cores, replacing MC602
2016-09-01 ME2082c, Malignant melanoma tissue array with normal tissue, including TNM and clinical stage, 208 cases/208 cores, replacing ME2082b
2016-08-31 BC081120b, Breast cancer array with adjacent normal breast tissue, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 110 cases/110 cores, replacing BC081120a
2016-08-31 T087c, Breast cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replacing T087b
2016-08-29 MC245a, Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 22 cases/24 cores, replacing MC245